Updated just now · Live
Stock analysis, price data, and AI-powered insights for Candel Therapeutics Inc (CADL).
Candel Therapeutics Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CADL.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CADL Stock Intelligence Report. [stoxpulse.com/stocks/cadl]
Disclaimer: The information on this page about Candel Therapeutics Inc (CADL) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Candel Therapeutics Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Candel Therapeutics: 'Cancer Vaccine' Buy Thesis A...
9h ago
Candel Therapeutics Stock Soars After Cantor Fitzg...
1d ago
StoxPulse AI results for CADL: Pulse Score 54/100. Primary sentiment trends from 6 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$528.8M
P/E Ratio
—
EPS
$-0.21
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Candel Therapeutics: 'Cancer Vaccine' Buy Thesis Appears Compelling
Candel Therapeutics Stock Soars After Cantor Fitzgerald's Overweight Rating
Candel Therapeutics shares are trading higher after Cantor Fitzgerald initiated its coverage on the stock with an Overweight rating.
Cantor Fitzgerald Initiates Coverage On Candel Therapeutics with Overweight Rating
10 Health Care Stocks Moving In Friday's Intraday Session
Candel Therapeutics : Website Candel April 2026 Corporate Presentation 230PM 041426 IR